An impairment exists when the carrying value of an asset exceeds its recoverable amount. The accounting principle is precise. The judgment embedded in its application is not.
The carrying value is known: it is the cost of the asset less accumulated depreciation and any prior impairment. The recoverable amount is estimated: it is the higher of the asset’s fair value less costs to sell, and its value in use (the present value of future cash flows the asset is expected to generate).
The impairment question, therefore, is not an accounting question. It is a forecasting question: what future cash flows will this asset generate, and are those cash flows sufficient to support the carrying value?
Management controls every input in the forecasting model. Revenue projections. Margin assumptions. Terminal growth rates. Discount rates. Capital expenditure plans. Working capital assumptions. Each input is a judgment, and each judgment can be set within a range of “reasonable” values that produces a materially different conclusion.
The Judgment Chain
Carrying value → cash flow forecast → terminal value → discount rate → recoverable amount → impairment or no impairment
Revenue projections
Revenue growth assumptions for impairment models are typically set by the same management team that developed the original investment thesis. The inherent bias is toward optimism, because a conservative revenue assumption might trigger the very impairment that management seeks to avoid.
The forensic test: compare the revenue assumptions in the impairment model to the actual revenue trajectory of the last three to five years. If actual growth has been 8% per annum but the impairment model assumes 15%, the model is not forecasting performance. It is forecasting the assumptions required to avoid a write-down.
Terminal value
Terminal value, the present value of all cash flows beyond the explicit forecast period, frequently represents 60% to 80% of the total recoverable amount. This means the impairment conclusion depends more on a perpetuity assumption about the indefinite future than on the five-year forecast that management presents with supporting detail.
A terminal growth rate of 4% versus 2% can shift the recoverable amount by 30% or more. The difference between impairment and no impairment may depend entirely on whether management assumes the business grows at 2% or 4% into perpetuity. Both assumptions are within the range of “reasonable.” They produce materially different conclusions.
Discount rate
The discount rate reflects the risk of the cash flows. A lower discount rate increases the present value and reduces the probability of impairment. A higher rate does the opposite.
The selection of the discount rate involves multiple judgments: the risk-free rate, the equity risk premium, the beta, the size premium and the country risk premium. Each of these can be estimated using different methodologies, different data sources and different time periods. The range of defensible discount rates for the same asset can span 2% to 4%, which translates to a 20% to 40% difference in recoverable amount.
The Forensic Inversion
In Northrop Management forensic practice, impairment analysis is tested by inverting the model: what combination of assumptions would trigger an impairment?
If the triggering assumptions are wildly unrealistic (revenue would have to decline by 50%, margins would have to halve, the discount rate would have to double), the carrying value is probably well-supported. The asset is genuinely worth what the balance sheet says.
If the triggering assumptions are within the range of plausible outcomes (a 3% reduction in growth, a 1% compression in margins, a 1% increase in the discount rate), the carrying value is fragile. It depends on management’s chosen assumptions holding, and any reasonable adverse movement would trigger a write-down.
The board should know where on this spectrum every significant asset sits.
Ashish Chaudhary, frames the governance question directly: “An impairment model is not an objective measurement. It is management’s opinion about the future, presented in the format of a calculation. The board’s job is to determine whether that opinion is informed by evidence or by the desire to avoid a write-down.”
Questions for the Boardroom
- For every material asset on our balance sheet, what combination of assumption changes would trigger an impairment, and how far are current conditions from those trigger points?
- Are the revenue and margin assumptions in our impairment models consistent with our actual recent performance, or do they reflect aspirational targets?
- What percentage of the recoverable amount in our impairment models is attributable to terminal value, and what growth rate are we assuming in perpetuity?
- If we changed our discount rate by 1%, how many assets would move from “no impairment” to “impairment required”?
- Is management forecasting the business, or forecasting the assumptions necessary to avoid an impairment?
Closing Implication
An impairment model can be mathematically precise and economically wrong at the same time. The precision of the calculation does not validate the assumptions behind it.
The board that treats the impairment model as a measurement is accepting management’s opinion as fact. The board that interrogates the assumptions, compares them to evidence, tests them through sensitivity analysis and asks what would trigger a different conclusion is performing the governance function that impairment testing was designed to require.
The asset is worth what the future cash flows support. Not what the model says. Not what management hopes. Not what the balance sheet needs. What the evidence, interrogated rigorously, actually shows.
